Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance

被引：0
|
作者：
Zatreanu, Diana A.
Robinson, Helen M. R.
Alkhatib, Omar
Boursier, Marie
Finch, Harry
Geo, Lerin
Grande, Diego
Grinkevich, Vera
Heald, Robert
Langdon, Sophie
Majithiya, Jayesh
McWhirter, Claire
Martin, Niall M. B.
Moore, Shaun
Neves, Joana
Rajendra, Eeson
Ranzani, Marco
Schaedler, Theresia
Stockley, Martin
Wiggins, Kimberley
Brough, Rachel
Sridhar, Sandhya
Gulati, Aditi
Shao, Nan
Badder, Luned M.
Novo, Daniela
Knight, Eleanor G.
Marlow, Rebecca
Haider, Syed
Callen, Elsa
Hewitt, Graeme
Schimmel, Joost
Prevo, Remko
Alli, Christina
Ferdinand, Amanda
Bell, Cameron
Blencowe, Peter
Calder, Mathew
Charles, Mark
Curry, Jayne
Ekwuru, Tennyson
Ewings, Katherine
Nussenzweig, Andre
Tijsterman, Marcel
Tutt, Andrew
Boulton, Simon J.
Higgins, Geoff S.
Pettitt, Steve
Smith, Graeme C. M.
Lord, Christopher J.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2021年 / 20卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-21-P056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P056
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia
    Brabson, John P.
    Leesang, Tiffany
    Yap, Yoon Sing
    Wang, Jingjing
    Lam, Minh Q.
    Fang, Byron
    Dolgalev, Igor
    Barbieri, Daniela A.
    Strippoli, Victoria
    Banuelos, Carolina P.
    Mohammad, Sofia
    Lyon, Peter
    Chaudhry, Sana
    Donich, Dane
    Swirski, Anna
    Roberts, Evan
    Diaz, Ivelisse
    Karl, Daniel
    Dos Santos, Helena Gomes
    Shiekhattar, Ramin
    Neel, Benjamin G.
    Nimer, Stephen D.
    Verdun, Ramiro E.
    Bilbao, Daniel
    Figueroa, Maria E.
    Cimmino, Luisa
    CELL REPORTS, 2023, 42 (01):
  • [22] Synthetic Lethality and PARP-Inhibitors in Oral and Head & Neck Cancer
    Forster, Martin
    Mendes, Ruheena
    Fedele, Stefano
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (34) : 5431 - 5441
  • [23] Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
    Angers, Stephane
    EMBO MOLECULAR MEDICINE, 2021, 13 (04)
  • [24] BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability
    Aly, Amal
    Ganesan, Shridar
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2011, 3 (01) : 66 - 74
  • [25] IGH/MYC Translocation in Burkitt Lymphoma Is Associated with BRCA2 Deficiency and Synthetic Lethality By PARP1 Inhibitors
    Maifrede, Silvia
    Martin, Kayla
    Podszywalow-Bartnicka, Paulina
    Katherine, Sullivan
    Langer, Samantha
    Nejati, Reza
    Dasgupta, Yashodhara
    Gritsyuk, Daniel
    Nieborowska-Skorska, Margaret
    Lupey, Lena
    Piwocka, Katarzyna
    Wasik, Mariusz A.
    Tempera, Italo
    Skorski, Tomasz
    BLOOD, 2016, 128 (22)
  • [26] BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance
    Wang, Yifan
    Bernhardy, Andrea J.
    Nacson, Joseph
    Krais, John J.
    Tan, Yin-Fei
    Nicolas, Emmanuelle
    Radke, Marc R.
    Handorf, Elizabeth
    Llop-Guevara, Alba
    Balmana, Judith
    Swisher, Elizabeth M.
    Serra, Violeta
    Peri, Suraj
    Johnson, Neil
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [27] BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance
    Yifan Wang
    Andrea J. Bernhardy
    Joseph Nacson
    John J. Krais
    Yin-Fei Tan
    Emmanuelle Nicolas
    Marc R. Radke
    Elizabeth Handorf
    Alba Llop-Guevara
    Judith Balmaña
    Elizabeth M. Swisher
    Violeta Serra
    Suraj Peri
    Neil Johnson
    Nature Communications, 10
  • [28] A novel SIK2 inhibitor SIC-19 exhibits synthetic lethality with PARP inhibitors in ovarian cancer
    Wang, Fang
    Yu, Xuejiao
    Qian, Jun
    Cao, Yumin
    Dong, Shunli
    Zhan, Shenghua
    Lu, Zhen
    Bast Jr, Robert C.
    Song, Qingxia
    Chen, Youguo
    Zhang, Yi
    Zhou, Jinhua
    DRUG RESISTANCE UPDATES, 2024, 74
  • [29] PARP-inhibitor-induced synthetic lethality for acute myeloid leukemia treatment
    Zhao, Lu
    So, Chi Wai Eric
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (10) : 902 - 907
  • [30] Synthetic lethality vs. synthetic viability due to PARP1 and BRCA2 loss
    Ding, Xia
    Sharan, Shyam K.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S441 - S442
12345